Nabla vs Suki AI
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Nabla
Ambient AI copilot that turns doctor-patient conversations into clinic...
Visit
|
|
|
|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 7.8 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Freemium | Enterprise |
| Free tier | Free trial available with core documentation features and limited usage | No free tier; demo only via sales contact |
| Paid from | Free tier (up to 30 consultations/mo); Pro ~$119/month (unlimited); enterprise via contract | ~$299/clinician/month (Compose); ~$399/clinician/month (Assistant) |
| Has API | ✓ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✗ |
| Users | 85,000+ clinicians across 150+ health organisations (mid-2025) | 350+ health systems; tens of thousands of clinicians |
| Founded | 2018 | 2017 |
| Maker | Nabla Technologies | Suki AI, Inc. (independent; strategic investor: Zoom Ventures) |
| Verdict | Nabla delivers one of the most clinically validated ambient AI scribes on the market. A NEJM AI randomised trial across 238 physicians and 48,000+ visits found a statistically significant 9.5% reduction in documentation... |
Suki AI is among the most capable ambient clinical documentation tools available, with genuinely deep EHR integrations — particularly its Epic "INSIDE" embedding and first-mover status on MEDITECH Expanse's documentation... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.